Application 209940

Type
NDA
Sponsor
MERCK SHARP DOHME

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PREVYMISLETERMOVIRSOLUTION;INTRAVENOUS240MG/12ML (20MG/ML)YesYes
002PREVYMISLETERMOVIRSOLUTION;INTRAVENOUS480MG/24ML (20MG/ML)YesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0006-5003PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5003PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5003PREVYMISLETERMOVIRMerck Sharp & Dohme LLCNDACurrent
0006-5003PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5003PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5003PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5003PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5003PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5004PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5004PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5004PREVYMISLETERMOVIRMerck Sharp & Dohme LLCNDACurrent
0006-5004PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5004PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5004PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5004PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent
0006-5004PREVYMISLETERMOVIRMerck Sharp & Dohme Corp.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
81087SUPPL 2025-02-06
80990SUPPL 2025-02-05
79521SUPPL 2024-10-15
79520SUPPL 2024-10-15
79535SUPPL 2024-09-03
79534SUPPL 2024-09-03
74991SUPPL 2023-08-04
74978SUPPL 2023-08-03
74453SUPPL 2023-06-06
74436SUPPL 2023-06-06
62303SUPPL2020-03-24
62280SUPPL2020-03-24
61447SUPPL2019-12-26
61418SUPPL2019-12-23
59896SUPPL2019-09-03
59884SUPPL2019-08-30
57925SUPPL2019-03-07
57920SUPPL2019-03-07
50756ORIG2017-12-18
50347ORIG2017-11-08
50346ORIG2017-11-08